DE3678541D1 - N-vinylimidazole und -triazole und diese enthaltende arzneimittel. - Google Patents

N-vinylimidazole und -triazole und diese enthaltende arzneimittel.

Info

Publication number
DE3678541D1
DE3678541D1 DE8686117943T DE3678541T DE3678541D1 DE 3678541 D1 DE3678541 D1 DE 3678541D1 DE 8686117943 T DE8686117943 T DE 8686117943T DE 3678541 T DE3678541 T DE 3678541T DE 3678541 D1 DE3678541 D1 DE 3678541D1
Authority
DE
Germany
Prior art keywords
vinylimidazoles
triazoles
products containing
medicinal products
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686117943T
Other languages
English (en)
Inventor
Masaru Ogata
Katsuya Tawara
Motohiko Ueda
Kosaburo Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of DE3678541D1 publication Critical patent/DE3678541D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8686117943T 1985-12-25 1986-12-23 N-vinylimidazole und -triazole und diese enthaltende arzneimittel. Expired - Fee Related DE3678541D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60294905A JPS62149666A (ja) 1985-12-25 1985-12-25 Ｎ−ビニルアゾ−ル類

Publications (1)

Publication Number Publication Date
DE3678541D1 true DE3678541D1 (de) 1991-05-08

Family

ID=17813772

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686117943T Expired - Fee Related DE3678541D1 (de) 1985-12-25 1986-12-23 N-vinylimidazole und -triazole und diese enthaltende arzneimittel.

Country Status (4)

Country Link
EP (1) EP0227100B1 (de)
JP (1) JPS62149666A (de)
KR (1) KR870006009A (de)
DE (1) DE3678541D1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0645604B2 (ja) * 1985-12-23 1994-06-15 エスエス製薬株式会社 イミダゾ−ル誘導体
DE3923153A1 (de) * 1989-07-13 1991-01-24 Basf Ag 1-halogen-vinylazole und diese enthaltende fungizide
DE3926365A1 (de) * 1989-08-04 1991-02-07 Schering Ag Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
DE4039559A1 (de) * 1990-12-07 1992-06-11 Schering Ag Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
DE4120107A1 (de) * 1991-06-14 1992-12-17 Schering Ag Bicyclisch substituierte vinylimidazole, -triazole und -tetrazole
EP0610444B1 (de) 1991-10-31 2003-01-29 ELFORD, Howard L. Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen
CA2297943A1 (en) * 1997-07-25 1999-02-04 Nippon Kayaku Kabushiki Kaisha Novel compound having effect of promoting neuron differentiation
TWI360535B (en) * 2007-08-30 2012-03-21 Univ Nat Sun Yat Sen Sulfur-containing compound, method of preparation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK157860C (da) * 1979-06-07 1990-07-30 Shionogi & Co Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf
JPS6036427B2 (ja) * 1980-12-05 1985-08-20 塩野義製薬株式会社 １−ベンジルイミダゾ−ル誘導体
CA1206970A (en) * 1981-10-01 1986-07-02 Hak-Foon Chan Substituted ethylenic imidazoles and triazoles
EP0079856A1 (de) * 1981-11-12 1983-05-25 Ciba-Geigy Ag Mikrobizide Triazolyl-vinyläther
DE3313499A1 (de) * 1983-04-14 1984-10-18 Hoechst Ag, 6230 Frankfurt 1,2,4-triazol-1-yl-vinylether, ihre herstellung und ihre verwendung als pflanzenbehandlungsmittel
US4539325A (en) * 1983-11-07 1985-09-03 Janssen Pharmaceutica N.V. 1-(2-Aryl-2-halo-1-ethenyl)-1H-azoles, and anticonvulsant use thereof
JPS60155163A (ja) * 1984-01-09 1985-08-15 Mitsui Toatsu Chem Inc イミダゾ−ル誘導体
US4629795A (en) * 1984-05-25 1986-12-16 Shionogi & Co., Ltd. Process for preparing imidazole derivatives
DE3533823A1 (de) * 1985-09-23 1987-04-02 Hoechst Ag Alkenylazole, verfahren zu ihrer herstellung und ihre verwendung
JPH0645604B2 (ja) * 1985-12-23 1994-06-15 エスエス製薬株式会社 イミダゾ−ル誘導体

Also Published As

Publication number Publication date
EP0227100B1 (de) 1991-04-03
KR870006009A (ko) 1987-07-08
EP0227100A2 (de) 1987-07-01
EP0227100A3 (en) 1988-06-22
JPS62149666A (ja) 1987-07-03

Similar Documents

Publication Publication Date Title
DK160557C (da) 1,8-naphthyridinforbindelser og farmaceutiske praeparater indeholdende saadanne
DE3689384D1 (de) Arzneimittel zur topischen Anwendung.
DE3578620D1 (de) Arzneimittel zur aeusserlichen anwendung.
DE69429821D1 (de) Farnesyl-derivate und diese enthaltende arzneimittel
DE3576276D1 (de) Phenothiazine enthaltende arzneimittel.
DE3685604T2 (de) 1,7-naphthyridinderivate und diese enthaltende arzneimittel.
ATE11048T1 (de) 2-guanidino-4-heteroarylthiazole und diese enthaltende arzneimittel.
IL86857A0 (en) Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
DE3866737D1 (de) Bisphosphonsaeure-derivate und sie enthaltende arzneimittel.
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
DE3481125D1 (de) Pheophorbidderivate und diese enthaltende pharmazeutische mittel.
DE68909501D1 (de) Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien.
NO870963L (no) Innretning for dosering og utdeling av vÿsker.
DE3678541D1 (de) N-vinylimidazole und -triazole und diese enthaltende arzneimittel.
DE3750067D1 (de) Disazoverbindungen und diese Disazoverbindungen enthaltende Zubereitungen.
DE3767794D1 (de) Trizyklische agonistenderivate von cholinergetischen rezeptoren und diese enthaltende arzneimittel.
ATE15372T1 (de) Hexahydro-trans-und tetrahydropyridoindolderivate und diese enthaltende neuroleptische mittel.
DE3874390D1 (de) Carboxystyrol-derivate und arzneimittel, die sie als wirkstoff enthalten.
DE69018914D1 (de) Pharmakologisch aktive Präparate und sie enthaltende Arzneimittel.
DE3871218D1 (de) Thiadiazol-derivate und diese derivate als wirksame bestandteile enthaltende insektizide und mitizide mittel.
DE3880307T2 (de) Perfluoralkene und fluorierungsprodukte davon.
PH23398A (en) Indenopyrimidine derivatives and pharmaceutical formulation containing the same
DE3683815D1 (de) Organozinnverbindungen und diese enthaltende pestizide.
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
JPS57183858A (en) Medical and pharmaceutical rubber product

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee